What is the immediate treatment for a pediatric asthma flare?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Treatment for Pediatric Asthma Flare

The immediate treatment for a pediatric asthma flare should include high-flow humidified oxygen, nebulized salbutamol (albuterol) 5 mg or terbutaline 10 mg, and oral prednisolone 1-2 mg/kg (maximum 40 mg). 1

Initial Assessment and Management

Assessment of Severity

  • Look for features of severe asthma:

    • Too breathless to talk or feed
    • Respiratory rate >50/min
    • Pulse >140/min
    • Use of accessory muscles of breathing
    • PEF <50% predicted (if child able to perform) 2
  • Life-threatening features requiring immediate intensive care consideration:

    • Cyanosis, silent chest
    • Poor respiratory effort
    • Fatigue or exhaustion
    • Agitation, reduced consciousness
    • PEF <33% predicted 2

Immediate Treatment Protocol

  1. Oxygen: Administer high-flow humidified oxygen via face mask 2, 1

  2. Bronchodilator:

    • Nebulized salbutamol 5 mg (0.15 mg/kg) or terbutaline 10 mg (0.3 mg/kg) 2
    • Alternative delivery: If nebulizer not available, use metered-dose inhaler (MDI) with spacer - give one actuation of salbutamol (100 mcg) then inhale, repeat up to 20 times 2
  3. Corticosteroids:

    • Oral prednisolone 1-2 mg/kg (maximum 40 mg) as a single dose 2, 3
    • For severe cases: IV hydrocortisone 100 mg six hourly 2

Delivery Method Considerations

MDI with spacer is as effective as nebulization for bronchodilator delivery:

  • Recent evidence shows MDI with spacer produces similar or better outcomes than nebulization 4
  • MDI with spacer is cheaper and more convenient than nebulizer 2
  • For very young children who cannot tolerate face masks and spacers, nebulizers are needed 2
  • Even non-valved spacers can be effective in delivering bronchodilators in stable asthmatic children 5

Monitoring and Further Management

Monitoring Response

  • Reassess after initial treatment
  • Monitor respiratory rate, heart rate, oxygen saturation, and work of breathing
  • For children able to perform: measure peak expiratory flow (PEF) 1

Further Management Based on Response

  1. If improving: Decrease frequency of bronchodilators as symptoms improve 2

  2. If not improving within 15-30 minutes:

    • Add ipratropium bromide 250 mcg six hourly via nebulizer 2, 1
    • Consider continuous nebulization of albuterol (0.3 mg/kg/hr) which has been shown to result in more rapid clinical improvement than intermittent nebulization 6
  3. If further deterioration:

    • Start aminophylline infusion (loading dose 5 mg/kg over 20 minutes, then 1 mg/kg/hour) - omit loading dose if already on theophylline 2
    • Consider transfer to intensive care for continuous bronchodilator therapy or mechanical ventilation 2

Discharge Planning

  • 24-48 hours before discharge, transition to discharge therapy using appropriate delivery system for the patient's age and technique 2
  • Continue oral prednisolone for up to five days 2
  • Ensure follow-up within 48 hours for patients treated at home 2
  • For hospitalized patients, arrange outpatient appointment within one month 2

Important Considerations

  • Avoid sedatives in patients with asthma 1
  • Recognize that asthma severity is often underestimated by patients and clinicians 1
  • Ensure proper education on inhaler technique before discharge 1
  • Consider hypertonic saline as diluent for nebulized albuterol, which may enhance bronchodilator response 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.